Solventum Corp. (SOLV)
89.08
+0.27
(+0.30%)
USD |
NYSE |
Nov 13, 16:00
89.56
+0.48
(+0.54%)
Pre-Market: 09:00
Solventum Net Income (Quarterly) : -12.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -12.00M |
| June 30, 2026 | 92.00M |
| March 31, 2026 | 13.00M |
| December 31, 2025 | 63.00M |
| September 30, 2025 | 1.266B |
| June 30, 2025 | 90.00M |
| March 31, 2025 | 137.00M |
| December 31, 2024 | 30.00M |
| Date | Value |
|---|---|
| September 30, 2024 | 122.00M |
| June 30, 2024 | 89.00M |
| March 31, 2024 | 237.00M |
| December 31, 2023 | 272.00M |
| September 30, 2023 | 460.00M |
| June 30, 2023 | 321.00M |
| March 31, 2023 | 293.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 141.17M |
| Edwards Lifesciences Corp. | 301.40M |
| Intuitive Surgical, Inc. | 524.40M |
| Stryker Corp. | 753.00M |
| Inspire Medical Systems, Inc. | -24.39M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.949B |
| Total Expenses (Quarterly) | 1.961B |
| EPS Diluted (Quarterly) | -0.0703 |
| Enterprise Value | 19.96B |
| Gross Profit Margin (Quarterly) | 55.00% |
| Profit Margin (Quarterly) | -0.62% |
| Earnings Yield | 1.00% |
| Operating Earnings Yield | 4.41% |
| Normalized Earnings Yield | 2.27 |